Important Compliance Disclosures
Strategy Risk. References to "non-directional," "low-correlated," "structural pricing patterns," and "quantitative market patterns" describe the program's design objectives and do not imply the absence of risk. The strategy may experience significant volatility and losses during periods of market stress, spread widening, or unexpected correlation shifts. These conditions can change rapidly, and there is no assurance the strategy will profit from identified patterns. Non-directional positioning does not guarantee reduced risk or positive returns in any market environment.
Derivatives, Leverage, and Instrument Risk. The program's strategies involve the use of derivatives, embedded leverage, futures options, securities options, and exchange-traded funds (ETFs) as selective tactical instruments. These approaches can increase portfolio volatility, magnify losses, and introduce risks — including margin risk, collateral risk, basis risk, liquidity risk, time decay, assignment risk, tracking error, and execution risk — not associated with traditional, cash-only investment portfolios. Options positions are subject to expiration, time decay, and the risk of total loss of premium paid. ETFs and options, when used, serve as tactical instruments within the overlay, not as the primary strategy vehicle. Collateral assets may decline in value simultaneously with overlay losses, compounding overall portfolio impact.
Operational and Fee Disclosures. References to "rules-based," "systematic," or "structured" implementation describe the program's operational methodology and do not imply reduced risk or predictable outcomes. The terms "portable alpha" and "return stacking" are used descriptively and do not imply guaranteed positive returns. NovoDyn generally earns incentive compensation only when account performance exceeds the applicable benchmark and high-water mark provisions, applicable to Qualified Client accounts as defined under SEC Rule 205-3. For Non-Qualified Client accounts, an annual flat fee of 1.75% of assets under management applies in lieu of a performance fee. For investors not represented by a financial advisor, a 1% annual futures replication fee also applies. Fee structures may vary by program and investor type. Prospective investors should review the applicable Disclosure Document for complete fee terms before investing.
General Disclosure and Registration. This website is for informational purposes only and does not constitute an offer to sell or solicitation to buy any commodity interest or security, and should not be relied upon as investment advice. Any offer will be made only through official offering documents, which should be carefully reviewed before investing. This website is intended solely for residents of the United States and does not constitute a solicitation or offer to any person in any jurisdiction outside the United States, including the European Economic Area. NovoDyn Advisors, LLC is registered with the CFTC as a Commodity Trading Advisor, is a Member of the National Futures Association (NFA ID #0435960), and is registered as an Investment Adviser (CRD #156451). Registration does not imply a certain level of skill or training. Trading futures and derivatives involves substantial risk of loss, is not suitable for all investors, and past performance is not necessarily indicative of future results.
